Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Daesiho-tang (DSHT) is a traditional Korean herbal medicine (Hanbang) formulation composed of multiple botanical extracts, including *Bupleurum falcatum*, *Scutellaria baicalensis*, and *Rheum palmatum*. It is traditionally used in East Asian medicine to treat acute febrile illnesses, habitual constipation, and chronic gastritis. In modern clinical research, particularly by Gachon University Gil Oriental Medical Hospital, it is being evaluated for its efficacy in treating obesity and metabolic syndrome. Preclinical evidence suggests that DSHT exerts anti-obesity effects by reducing body weight, liver and adipose tissue mass, and improving lipid profiles (total cholesterol, triglycerides, HDL) and glucose tolerance. It is currently being studied in Phase 4 clinical trials in South Korea for these metabolic indications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Daesiho-tang.